Founded on the belief that a better world begins with a better you.
IntellxxDNA is a genomics intelligence services company, created to individualize the practice of medicine by empowering functional and integrative clinicians with molecular-level insight into each patient, realizing evidence-based, precision treatment — and nurturing a new level of healing and care for the patient, for society and for our planet.
Led by a board-certified MD and dedicated genomics professionals, we are a trusted curator of the vast and ever-changing volume of medical genomic data.
Dr. Sharon Hausman-Cohen
Co-Founder, Chief Science Officer, & Medical Director
Dr. Hausman-Cohen has been using genomics for over a decade to deliver personalized medicine and help her patients achieve optimal health and wellness. READ FULL BIO
Our Co-Founder, Chief Science Officer, and Medical Director, Dr. Sharon Hausman-Cohen, has been using genomics for over a decade to deliver personalized medicine and help her patients achieve optimal health and wellness. As a researcher and clinician advocate, she recognized that information inaccuracies and complexity were barriers to entry for many. She saw the need for an easy-to-use, accurate, science-based genomics interpretation tool for clinicians, and began to develop what is now IntellxxDNA™. In addition to being a well-regarded doctor and researcher, Dr. Hausman-Cohen is a sought after speaker and educator on genomics, personalized medicine and integrative medicine. Dr. Hausman-Cohen received both her master’s and medical degrees from Harvard Medical School. Board-certified in Family Medicine, she is a Fellow of the American Board of Integrative and Holistic Medicine, possessing additional board certification in Integrative Medicine through the American Board of Physician Specialties. She has been practicing Full Spectrum Family Medicine and Integrative Medicine for more than 20 years.
Carol Bilich
Co-Founder and CEO
Carol Bilich is a mission-driven CEO, passionate about building a company that is firmly rooted in research integrity, business/medical ethics and the development of a healthy corporate culture. READ FULL BIO
Carol Bilich, IntellxxDNA™ Co-Founder and CEO, is not the stereotypical corporate CEO. She is passionate about building a mission-driven company that is firmly rooted in research integrity, business/medical ethics and the development of a healthy corporate culture. An integrative medicine practitioner for over 20 years, Carol began conducting in-depth research in genomics as a way to better understand and help her patients. Over time, she acquired vast knowledge of supplement efficacy and complementary healing modalities. However, Carol’s passion for integrative medicine and genomics reached a new level when she saw improved outcomes within her own wellness journey. As Carol says, “It’s one thing to be a clinician discussing genomics, and another to experience healing, firsthand, through genomics-based interventions.” Carol received both undergraduate and graduate degrees from the University of Texas and obtained a Certification in Business Entrepreneurship from Texas State University. She has launched three thriving businesses, one of which is a well-regarded, full spectrum concierge practice serving the greater Austin area.
Connie Trotter
Chief Operating Officer
Over the span of a 30-year career in healthcare operations, Connie Trotter has brought clarity, efficiency and problem-solving to some of the most successful practices in Austin, Texas, including concierge medicine, family medicine, dialysis clinics and cardiology. In addition to bringing her critical operational and managerial responsibilities to IntellxxDNA, our clinician clients rely on Connie for her experience and insight in successfully deploying our decision support tool in their practices.
Mike Sheridan
Director of Growth
Mike manages the IntellxxDNA go-to-market initiatives to help meet the company goal of making genomics widely available to patients suffering from chronic disease. Mike brings a wealth of sales and marketing leadership experience from start-ups like Inbox Health to mid-size enterprises like Aspect Software applying a strategic, customer-centric approach to deliver sustainable growth. With an eye towards using data derived insights, he employs a collaborative style in working with customers, internal teams, and channel partners to remove barriers, implement change, and grow teams.
Mike holds a Master of Science in Computer Science from Depaul University.
Todd McConnell
Chief Technology Officer
Todd has almost 30 years working with commercial, government, and healthcare agencies providing support with their technology and business needs. He loves working with customers and helping them watch their visions converted into working successful IT systems. For the past 8 years he has been focused on melding technology and genetics to design the IntellxxDNA system. Todd joins the IntellxxDNA team to further support this team of highly innovative individuals. Todd is excited to join the IntellxxDNA team as we continue to expand and break new ground advancing genetic research and bringing the practical application to people around the world.
Jordan Reeder
Research Associate
Jordan is an integral part of the R&D team and wears many hats with us at IntellxxDNA. He works closely with Dr. Hausman-Cohen and our consulting scientists to help cull and then translate the published medical literature into IntellxxDNA reports. In addition to research, Jordan works with the laboratory, bioinformatics consultants, and design team to help improve the scientific and clinical utility of the IntellxxDNA platform. And finally, Jordan is a great teacher, helping to train our providers on the use of genomics in practice. He is a passionate researcher who firmly believes the power of genomics will advance medicine. He truly enjoys untangling the challenging puzzles that are often found in the world of genomics.
Jordan holds a Master of Science in Biology with a focus in Microbiology and Cellular Biology.
Andrea Sanchez
Marketing Associate
Andrea is on our marketing team at IntellxxDNA, where she is responsible for establishing a meaningful connection with our providers. She works heavily with our CEO in developing and maintaining our online education platform, connecting the dots for us with everything related to workshop development, IT, and updating the world about what we’re up to! She is a creative and talented artist as well as a film editor. Without her, Genomics University would not be possible. As a former part of the clinical staff at Dr. Hausman-Cohen’s practice, Resilient Health, Andrea has developed a unique perspective on genomics and patient care. A self-described curious thinker, Andrea is committed to the growth and innovation of IntellxxDNA. She is currently most passionate about the work she is doing to grow IntellxxDNA’s presence in the field of personalized medicine.
Andrea holds a Bachelor of Science from the University of Texas.
IntellxxDNA routinely consults with MDs and PhDs from around the world in an effort to continually provide clinically useful genomic intelligence. We are honored to be among these valued advisors.
Arwen Podesta, M.D.
Dr. Podesta is a board certified psychiatrist and nationally recognized expert in the field of addiction. Her background in biochemistry and genetics has positioned her to be an ideal consultant to IntellxxDNA as we developed our Mental Wellness Report. She is currently involved in research regarding addiction and the role of NAD as well as serving as a psychiatrist with additional specialties in integrative and forensic medicine. In addition to helping to connect potential interventions and genomic mechanisms in our Addiction panel, she has served as an educator as part of our IntellxxDNA trainings.
Robert Sheeler, M.D.
Dr. Sheeler is a global thought leader in the world of both Integrative and Functional Medicine. After 20 years in numerous leadership positions including faculty, Clinical Practice Chair for the Department of Family Medicine and the Family Medicine Clerkship Director at the Mayo Clinic Medical School, Dr. Sheeler went into private practice so that he could be truly at the forefront of medicine. He teaches Functional Medicine across the globe and has been an early adopter of genomics, using IntellxxDNA since its inception. His insight, feedback, beta testing and recommendations for interventions during the development process of our reports and beyond has helped us create one of the most highly respected genomic products in the country.
Angela O’Neil, M.D.
Dr. Angela O’Neil, who is Board Certified in Family Medicine and Integrative Medicine and who is a Certified Functional Medicine Practitioner, was previously the Assistant Dean and Assistant Professor of the Mayo Medical School. Her focus in Child and Adolescent Health as well as Women’s health has offered IntellxxDNA insight as she beta tested our medical overview report. Dr. O’Neil’s feedback has also helped us as we move forward to address concerns of all ages including topics such as ADHD, other topics contributing to mental wellness and future development on reports designed for women’s health. Dr. O’Neil has been using IntellxxDNA since its inception.
Heather Way, PhD.
Dr. Heather Way is the head of the Australian Centre for Genomic Analysis. As a specialist in Autism, genomics and nutrition, Dr. Way has helped almost 1000 children dramatically improve their quality of life, often going from non-verbal to being mainstreamed. Dr. Way was the inspiration for our Neurodevelopmental Genomics Report and has been instrumental in the research and development of this report which is geared toward helping individuals with Autism and other neurodevelopmental disorders. Her love and support as well as her tremendous knowledge has helped IntellxxDNA become the first Clinical Decision Support tool that has a report designed specifically for identifying modifiable contributing factors to neurodevelopmental conditions.
Brian Cornblatt, PhD.
Dr. Brian Cornblatt has spent over 20 years studying phytonutrients starting with bench work during his days at John’s Hopkins, all the way through human clinical trials for health promotion. He has focused on the ability of these substances to modulate expression of detoxication and anti-oxidative enzymes as well as their regulation of key molecular pathways. His most recent research has focused on Autism and mental health topics like cognition and schizophrenia. A recognized global expert on cellular detoxification pathways and their underlying genomic contributors, Dr. Cornblatt has consulted with our scientific research team as we have worked to untangle complicated genomics. He has also helped us understand fundamentals that have contributed to the development of our detox and inflammation panels which are key to health and wellness.
Request a Clinician Account
Available only to licensed health care professionals, your IntellxxDNA account will be your dedicated portal to your patients’ reporting, training and support materials and other information of assistance.
